@xconomy.com 1 year ago
Acelity Sells to 3M in Deal Valued at $6.7 Billion, Ending IPO Plan
@xconomy.com 1 year ago
San Antonio Wound-Care Company Eyes (Another) Initial Public Offering
@xconomy.com 1 year ago
With New Data, Intercept On Track for First-Ever Approved NASH Drug
@xconomy.com 1 year ago
San Antonio Life Science Business Acelity Cuts 260 Jobs in Texas, NC
@xconomy.com 1 year ago
With Big Takeda Deal at Launch, Can Ambys Keep Control of Its Future?